Correction to “Avelumab combined with axitinib for patients with advanced thymoma B3 and thymic carcinoma”

Cancer 2026

View at publisher
DOI: 10.1002/cncr.70295
Cited by: 0

Abstract

Conforti F, Pala L, Catania C, et al. Avelumab combined with axitinib for patients with advanced thymoma B3 and thymic carcinoma. Cancer. 2025;e70092. doi:10.1002/cncr.70092 In the published version of this article, the affiliation of Matteo Perrino was reported incorrectly. The correct affiliation should read: Department of Oncology, IRCCS Humanitas Research Hospital, Milan, Italy. We apologize for this error.

Fields of Study & Subjects

Myasthenia Gravis and Thymoma Cancer Immunotherapy and Biomarkers T-cell and B-cell Immunology

Publication details

Journal / source
Cancer
Volume
132
Issue
4
Pages
e70295–e70295
Publication date
10 February 2026
Language
EN